Economic Atlas
Companies/Co-Diagnostics, Inc.
Company profile

Co-Diagnostics, Inc.

NASDAQ: CODX · Healthcare · Biotechnology
PublicHQ Salt Lake City, UT · Salt LakeCIK 0001692415Reports USD
#919 of 1,422 Healthcare companies by revenuebottom-quartile growth
EA Score
33D
Revenue TTM
$718.2k
Rev growth YoY (TTM)
-79.5%
Net income (FY)
-$46.9M
Employees
115
as of 2026-08-24
Market cap
$1.4M
as of 2026-08-24

Financials — latest annual

SEC EDGAR · USD-normalized
ConceptUSDNativeFY
Revenue$622.5k$622.5k2025
Net income-$46.9M-$46.9M2025
Operating income-$50.2M-$50.2M2025
Total assets$24.7M$24.7M2025
Liabilities$4.1M$4.1M2025
Equity$20.6M$20.6M2025

Revenue trend

FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25

Revenue by segment

Filed disclosures · FY2025
By product
Product67%
Grant33%
By geography
UNITED STATES93%
Non-US7%
The read

What is Co-Diagnostics, Inc.’s revenue?

Co-Diagnostics, Inc. booked $622.5k in FY2025 revenue, contracting 84% year over year — slower than 89% of Healthcare companies we track, at a -7533.6% net margin.

Peers · Healthcare
BioXcel Therapeutics, Inc.27DComera Life Sciences Holdings, Inc.——CEN Biotech, Inc.——NovelStem International Corp.37DTheralink Technologies, Inc.——Vaccinex, Inc.——
Neighbors
Salt Lake →
Extra Space Storage Inc.$129.5M67BZions Bancorporation, National Association$529.0M57CHealthEquity, Inc.$1.3B82B+Merit Medical Systems, Inc.$1.5B83B+Rest Ez Inc.$0——PROG Holdings, Inc.$2.4B72B
Key facts
CEODwight Egan
SectorHealthcare
IndustryBiotechnology
HeadquartersSalt Lake City, UT
ExchangeNASDAQ: CODX
Employees115
IPO date2017-07-12
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.